Prenatal methadone exposure and neonatal neurobehavioral functioning.
Opioid-exposed infants display a wide and variable range of dysregulated neurobehavioral functioning, but the regulatory difficulties experienced by these infants outside the defined clusters of neonatal abstinence syndrome (NAS) have not been well described and may have implications for the infant's developmental course. This study describes the neurobehavioral functioning of neonates prenatally exposed to methadone, using the NICU Network Neurobehavioral Scale (NNNS), and explores the relationships between maternal factors and infant functioning. The relationship between NNNS measures, NAS severity, and need for pharmacotherapy for NAS was also evaluated. Infants who required pharmacologic treatment for NAS showed more dysregulated behavior and signs of stress and abstinence as indicated by NNNS scores, but NNNS scores were not significantly correlated with maternal methadone dose. The determination of the range of the methadone-exposed infant's neurobehavioral repertoire could guide the optimal treatment of all such infants, particularly those requiring only nonpharmacologic care.
Velez
Martha L
ML
Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA.
Jansson
Lauren M
LM
Schroeder
Jennifer
J
Williams
Erica
E
D000704:Analysis of Variance; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D053609:Lethargy / Q000139:chemically induced; D018811:Maternal Exposure; D008691:Methadone / Q000009:adverse effects*; D009068:Movement / Q000187:drug effects; D009122:Muscle Hypertonia / Q000139:chemically induced; D009123:Muscle Hypotonia / Q000139:chemically induced; D009357:Neonatal Abstinence Syndrome / Q000473:pathology*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000503:physiopathology*; D012021:Reflex, Abnormal / Q000187:drug effects; D013312:Stress, Physiological / Q000187:drug effects
D008691:Methadone
Drug Alcohol Depend. 2004 Sep 6;75(3):253-60
15283946
Int J Neuropsychopharmacol. 2003 Sep;6(3):253-65
12974992
J Opioid Manag. 2009 Jan-Feb;5(1):47-55
19344048
Neurol Clin. 2000 Aug;18(3):541-62
10873230
Pediatrics. 1996 Jul;98(1):71-5
8668415
Neurotoxicol Teratol. 2008 Jan-Feb;30(1):20-8
18031987
J Epidemiol Community Health. 2001 Sep;55(9):687-8
11548709
J Matern Fetal Neonatal Med. 2007 Sep;20(9):677-85
17701668
J Pediatr. 2006 Dec;149(6):781-7
17137892
BJOG. 2009 Apr;116(5):665-71
19220239
Pediatrics. 1974 Nov;54(5):583-6
4453456
Harm Reduct J. 2008 Feb 06;5:6
18254953
Arch Dis Child Fetal Neonatal Ed. 2005 Jan;90(1):F73-4
15613582
J Addict Dis. 1993;12(4):45-57
8292639
J Addict Med. 2008 Sep;2(3):113-20
19727440
Pediatrics. 2002 Dec;110(6):1182-92
12456917
Addict Dis. 1975;2(1-2):141-58
1163358
J Subst Abuse Treat. 1996 Jul-Aug;13(4):321-9
9076650
Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):606-10
16150249
Pediatrics. 1982 Aug;70(2):210-3
7099786
Ann N Y Acad Sci. 1998 Jun 21;846:296-305
9668416
Pediatrics. 1998 Jun;101(6):1079-88
9614425
Am J Obstet Gynecol. 2003 Aug;189(2):312-7
14520184
Pediatr Pharmacol (New York). 1982;2(2):113-20
12760403
Pediatrics. 2008 Jan;121(1):106-14
18166563
Pediatrics. 2004 Mar;113(3 Pt 2):676-8
14993526
J Subst Abuse Treat. 1992;9(3):199-213
1334156
Pediatrics. 2003 Jun;111(6 Pt 1):1318-23
12777547
Am J Orthopsychiatry. 1993 Apr;63(2):266-76
7683453
Pediatrics. 2004 Mar;113(3 Pt 2):641-67
14993524
Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):611-7
16150250
Neurotoxicol Teratol. 1997 Jul-Aug;19(4):295-303
9253008